Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease

Trajectories of forced vital capacity in patients with systemic sclerosis-associated interstitial lung disease

Abstract We used data from the SENSCIS and SENSCIS-ON trials to assess decline in forced vital capacity (FVC) in patients with systemic sclerosis-associated interstitial lung disease (SSc-ILD) who received long-term treatment with nintedanib and the effect of switching patients from placebo to ninte...

Full description

Saved in:
Bibliographic Details
Main Authors: Oliver Distler, Madelon C Vonk, Arata Azuma, Maureen D. Mayes, Dinesh Khanna, Kristin B. Highland, Gerrit Toenges, Margarida Alves, Yannick Allanore
Format: Article
Language:English
Published: BMC 2025-03-01
Series:Arthritis Research & Therapy
Subjects:
Disease progression
Pulmonary fibrosis
Pulmonary function tests
Systemic scleroderma
Online Access:https://doi.org/10.1186/s13075-025-03524-9
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1186/s13075-025-03524-9

Similar Items